Winnie Yeo
Agency for Science, Technology and Research(SG)Chinese University of Hong Kong(HK)Chinese University of Hong Kong(CN)Samsung Medical Center(KR)Prince of Wales Hospital(CN)National Cancer Center Hospital East(JP)University of Otago(NZ)Sungkyunkwan University(KR)University of Hong Kong(HK)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial(2017)4,261 cited
- → Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade(2014)2,677 cited
- → Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab(2008)628 cited
- → Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors(2000)628 cited
- → Extranodal Natural Killer T-Cell Lymphoma, Nasal-Type: A Prognostic Model From a Retrospective Multicenter Study(2005)612 cited
- →